⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL261678 | 0.80 | ALDH1A1 (0.40) | — | |
| SCHEMBL2947883 | 0.76 | — | — | |
| SCHEMBL22024413 | 0.71 | ALDH1A1 (0.38) | — | |
| SCHEMBL4685982 | 0.71 | — | — | |
| SCHEMBL12854154 | 0.71 | — | — | |
| SCHEMBL17368397 | 0.71 | ALDH1A1 (0.38) | — | |
| SCHEMBL4685983 | 0.71 | — | — | |
| SCHEMBL4685300 | 0.70 | ALDH1A1 (0.37) | — | |
| SCHEMBL4684833 | 0.69 | ALDH1A1 (0.31) | — | |
| SCHEMBL4684827 | 0.69 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2736909-B1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | FARMA GRS D O O (SI) | 2017-03-29 | — | — | EP | claimed |
| EP-2736909-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | Farma GRS, d.o.o. (SI) | 2014-06-04 | — | — | EP | claimed |
| WO-2013013833-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | FARMA GRS, D.O.O. (SI) | 2013-01-31 | — | — | WO | claimed |
| US-20050171165-A1 | Process for the preparation of perindopril | GLENMARK PHARMACEUTICALS LIMITED (IN) | 2005-08-04 | — | — | US | claimed |
| EP-0719280-B1 | PROCESS FOR THE PREPARATION OF COMPOUNDS HAVING ACE INHIBITORY ACTION AS WELL AS NOVEL COMPOUNDS USEFUL AS STARTING MATERIALS OR INTERMEDIATES IN SAID PROCESS | LEK TOVARNA FARMACEVTSKIH (SI) | 1999-11-10 | — | — | EP | claimed |
| US-5789597-A | ANGIOTENSIN CONVERTING ENZYME, ENALAPRIL MALEATE | LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, D.D. (SI) | 1998-08-04 | — | — | US | claimed |
| EP-0719280-A1 | PROCESS FOR THE PREPARATION OF COMPOUNDS HAVING ACE INHIBITORY ACTION AS WELL AS NOVEL COMPOUNDS USEFUL AS STARTING MATERIALS OR INTERMEDIATES IN SAID PROCESS | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) | 1996-07-03 | — | — | EP | claimed |
| WO-1996002564-A1 | PROCESS FOR THE PREPARATION OF COMPOUNDS HAVING ACE INHIBITORY ACTION AS WELL AS NOVEL COMPOUNDS USEFUL AS STARTING MATERIALS OR INTERMEDIATES IN SAID PROCESS | LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, D.D. (SI) | 1996-02-01 | — | — | WO | claimed |
| EP-2736909-B1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | FARMA GRS D O O (SI) | 2017-03-29 | — | — | EP | disclosed |
| EP-2736909-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | Farma GRS, d.o.o. (SI) | 2014-06-04 | — | — | EP | disclosed |
| WO-2013013833-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | FARMA GRS, D.O.O. (SI) | 2013-01-31 | — | — | WO | disclosed |
| EP-1628956-B1 | A PROCESS FOR THE PREPARATION OF COMPOUNDS HAVING AN ACE INHIBITORY ACTION | LEK PHARMACEUTICALS (SI) | 2010-11-17 | — | — | EP | disclosed |
| US-7671215-B2 | Process for the preparation of compounds having an ace inhibitory action | LEK PHARMACEUTICALS, D.D. (SI) | 2010-03-02 | — | — | US | disclosed |
| US-20070072919-A1 | Process for the preparation of compounds having an ace inhibitory action | LEK PHARMACEUTICALS, D.D. (SI) | 2007-03-29 | — | — | US | disclosed |
| US-4855295-A | Tetrahydro-beta-carbolines, and their use as drugs | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-08-08 | — | — | US | disclosed |
| US-4778800-A | ANXIOLYTIC, ANTICONVULSANT | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-10-18 | — | — | US | disclosed |
| US-4757070-A | 3-oxadiazolyl-5-aminoalkyl-beta-carboline derivatives compositions and use | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-07-12 | — | — | US | disclosed |
| US-4731365-A | 5-aminoalkyl-beta-carboline derivatives, psycho tropic compositions and use | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-03-15 | — | — | US | disclosed |
| US-4623649-A | PSYCHOPHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-11-18 | — | — | US | disclosed |
| US-4600715-A | CENTRAL NERVOUS SYSTEM | SHERING AKTIENGESELLSCHAFT (DE) | 1986-07-15 | — | — | US | disclosed |